Sara Traserra
Oral Hyoscine butylbromide exerts spasmolytic effects both in gastrointestinal and urogenital tissues
Traserra, Sara; Appelqvist, Terence; Lange, Robert; Corsetti, Maura; Jimenez, Marcel
Authors
Terence Appelqvist
Robert Lange
Dr MAURA CORSETTI Maura.Corsetti@nottingham.ac.uk
CLINICAL ASSOCIATE PROFESSOR
Marcel Jimenez
Abstract
Background and Purpose: Hyoscine butylbromide (HBB) has a low oral (PO) bioavailability. Further, limited data on its activity on non-gastrointestinal (GI) smooth muscle spasms after oral dosing are available, meaning its effect outside the GI tract has been questioned. This pharmacokinetic/pharmacodynamic (PK/PD) study, conducted using female rats, aims to cover this gap.
Experimental Approach: PK study: HBB and atropine (comparator) were administered PO and IV to rats, and concentrations in plasma, and colon, uterus and urinary bladder (CUB) were measured. PD study-1: Concentration–response (C-R) curves of HBB and atropine (10−9–10−4 M) were obtained for carbachol (CCH)-induced (10−5 M) pre-contracted CUB; PD study-2: CUB were pre-incubated with HBB and atropine at maximum concentrations (Cmax) from PK study, and CCH C-R curves (10−9–10−4 M) were obtained; PD study-3: HBB and atropine were administered PO and IV to rats as for PK study, CUB were collected at 0.5 h (IV) and 4 h (PO), and CCH C-R curves (10−9–10−4 M) were obtained.
Key Results: PO HBB showed higher Cmax in CUB (192.5, 3.70 and 1.85 ng∙g−1, respectively) than plasma (0.008 ng∙mL−1). HBB and atropine reduced (concentration dependently) CCH-induced contractions in CUB. PO HBB showed highest spasmolytic activity in colon (40%), followed by uterus (30%) and urinary bladder (10%).
Conclusion and Implications: This is the first comparative study investigating PO and IV HBB and atropine in GI and non-GI tissues. Despite low bioavailability, PO HBB accumulates and exerts spasmolytic effects outside the GI tract.
Citation
Traserra, S., Appelqvist, T., Lange, R., Corsetti, M., & Jimenez, M. (in press). Oral Hyoscine butylbromide exerts spasmolytic effects both in gastrointestinal and urogenital tissues. British Journal of Pharmacology, 1-40
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 17, 2024 |
Deposit Date | Dec 18, 2024 |
Print ISSN | 0007-1188 |
Electronic ISSN | 1476-5381 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Pages | 1-40 |
Keywords | PK/PD study; smooth muscle; colon; urinary bladder; uterus. |
Public URL | https://nottingham-repository.worktribe.com/output/43095148 |
Publisher URL | https://bpspubs.onlinelibrary.wiley.com/journal/14765381 |
This file is under embargo due to copyright reasons.
You might also like
Reply
(2024)
Journal Article
Ondansetron for irritable bowel syndrome with diarrhoea: randomised controlled trial
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search